@article{0e19533a519d485fa114985ac6b1cfb9,
title = "Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission",
abstract = "Although considerable evidence suggests that the chemical synapse is a lynchpin underlying affective disorders, how molecular insults differentially affect specific synaptic connections remains poorly understood. For instance, Neurexin 1a and 2 (NRXN1 and NRXN2) and CNTNAP2 (also known as CASPR2), all members of the neurexin superfamily of transmembrane molecules, have been implicated in neuropsychiatric disorders. However, their loss leads to deficits that have been best characterized with regard to their effect on excitatory cells. Notably, other disease-associated genes such as BDNF and ERBB4 implicate specific interneuron synapses in psychiatric disorders. Consistent with this, cortical interneuron dysfunction has been linked to epilepsy, schizophrenia and autism. Using a microarray screen that focused upon synapse-associated molecules, we identified Cntnap4 (contactin associated protein-like 4, also known as Caspr4) as highly enriched in developing murine interneurons. In this study we show that Cntnap4 is localized presynaptically and its loss leads to a reduction in the output of cortical parvalbumin (PV)-positive GABAergic ({\^I} 3-aminobutyric acid producing) basket cells. Paradoxically, the loss of Cntnap4 augments midbrain dopaminergic release in the nucleus accumbens. In Cntnap4 mutant mice, synaptic defects in these disease-relevant neuronal populations are mirrored by sensory-motor gating and grooming endophenotypes; these symptoms could be pharmacologically reversed, providing promise for therapeutic intervention in psychiatric disorders.",
author = "T. Karayannis and E. Au and Patel, {J. C.} and I. Kruglikov and S. Markx and R. Delorme and D. H{\'e}ron and D. Salomon and J. Glessner and S. Restituito and A. Gordon and L. Rodriguez-Murillo and Roy, {N. C.} and Gogos, {J. A.} and B. Rudy and Rice, {M. E.} and M. Karayiorgou and H. Hakonarson and B. Keren and G. Huguet and T. Bourgeron and C. Hoeffer and Tsien, {R. W.} and E. Peles and G. Fishell",
note = "Funding Information: Acknowledgements The authors are grateful to R. Froemke for critically reading the manuscript, to B. Benedetti, M. McKenzie Chang, L. Cobbs, B. A. Heller, T. Petros and N. Yumoto (all NYU) for help with experiments and analysis and to Charles Nicholson (NYU) for providing specialized software to analyse Vmax. Research in the Fishell laboratory is supported by the NIH (grants R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972 to B.R. and G.F.) and the Simons Foundation (94534). The Rice laboratory is supported by the NIH (grants R01 NS036362 and R01 DA033811) and the Attilio and Olympia Ricciardi Research Fund. The Rudy laboratory is supported by the NIH (NS30989). The Peles laboratory is supported by the NIH (grant NS50220) and the Israel Science Foundation. T.K. support was provided through postdoctoral fellowshipsfrom the PattersonTrust andRoche.E.A.supportwas providedbyNewYork State through its NYSTEM initiative (C024326) and fellowship from Canadian Institutes of Health Research. J.C.P support was provided by NYU COE Addiction Seed Grant. This work was funded by the Institut Pasteur, INSERM, AP-HP, University Paris Diderot and the Bettencourt-Schueller, Orange, FondaMental, Conny-Maeva, Cognacq-Jay foundations.",
year = "2014",
doi = "10.1038/nature13248",
language = "English (US)",
volume = "511",
pages = "236--240",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7508",
}